Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant polycystic kidney disease in which the cause of the disease is a mutation in the ALG9 gene.
No clinical trials have been registered for ALG9-associated autosomal dominant polycystic kidney disease.
9 publications have been identified in PubMed for ALG9-associated autosomal dominant polycystic kidney disease. Research spans Basic Science / Preclinical (56%), Review / Meta-Analysis (22%), and Epidemiology / Natural History (22%).
Bou Antoun MT (2026). [PMID: 41212622](https://pubmed.ncbi.nlm.nih.gov/41212622/). *J Am Soc Nephrol*. [Review / Meta-Analysis]
Varughese S (2026). [PMID: 40810452](https://pubmed.ncbi.nlm.nih.gov/40810452/). *Nephrol Dial Transplant*. [Epidemiology / Natural History]
Jawaid T (2025). [PMID: 39899384](https://pubmed.ncbi.nlm.nih.gov/39899384/). *J Am Soc Nephrol*. [Basic Science / Preclinical]
Aypek H (2025). [PMID: 41032671](https://pubmed.ncbi.nlm.nih.gov/41032671/). *Ren Fail*. [Basic Science / Preclinical]
Elhassan EAE (2025). [PMID: 39881088](https://pubmed.ncbi.nlm.nih.gov/39881088/). *J Nephrol*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Nov 4, 2026, 2:18 PM UTC
Yang JL (2024). [PMID: 39183159](https://pubmed.ncbi.nlm.nih.gov/39183159/). *Zhonghua Nei Ke Za Zhi*. [Basic Science / Preclinical]
Clark D (2024). [PMID: 39136524](https://pubmed.ncbi.nlm.nih.gov/39136524/). *Am J Med Genet A*. [Basic Science / Preclinical]
Mori T (2024). [PMID: 39698362](https://pubmed.ncbi.nlm.nih.gov/39698362/). *Kidney Int Rep*. [Basic Science / Preclinical]
Mahboobipour AA (2024). [PMID: 38671465](https://pubmed.ncbi.nlm.nih.gov/38671465/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
AI-curated news mentioning ALG9-associated autosomal dominant polycystic kidney disease
Updated Oct 20, 2026
A new analytics platform, MEDA-PKD, has been developed for precision care in autosomal dominant polycystic kidney disease. This dynamic, real-time tool aims to enhance patient management and treatment outcomes.
A case study highlights extensive parenchymal brain calcification in a patient with autosomal dominant polycystic kidney disease and stage 5 chronic kidney disease. This research contributes to understanding the neurological implications of these conditions.
A case report highlights biallelic PKD1 mutations leading to neonatal death in a preterm infant, emphasizing the severe implications of very early-onset autosomal dominant polycystic kidney disease (ADPKD). This study contributes to the understanding of genetic factors in neonatal outcomes.